CLINICAL_TRIALS
trial_result
· 2010-08-31
Clinical Trial Update: A Study of Abatacept in Patients With Active Crohn's Disease [Phase 3]
Summary
A Phase 3 trial evaluating abatacept for active Crohn's disease was terminated, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2010-08-31